<code id='966A4B8DEC'></code><style id='966A4B8DEC'></style>
    • <acronym id='966A4B8DEC'></acronym>
      <center id='966A4B8DEC'><center id='966A4B8DEC'><tfoot id='966A4B8DEC'></tfoot></center><abbr id='966A4B8DEC'><dir id='966A4B8DEC'><tfoot id='966A4B8DEC'></tfoot><noframes id='966A4B8DEC'>

    • <optgroup id='966A4B8DEC'><strike id='966A4B8DEC'><sup id='966A4B8DEC'></sup></strike><code id='966A4B8DEC'></code></optgroup>
        1. <b id='966A4B8DEC'><label id='966A4B8DEC'><select id='966A4B8DEC'><dt id='966A4B8DEC'><span id='966A4B8DEC'></span></dt></select></label></b><u id='966A4B8DEC'></u>
          <i id='966A4B8DEC'><strike id='966A4B8DEC'><tt id='966A4B8DEC'><pre id='966A4B8DEC'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:3
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Shionogi licenses Pompe disease therapy from Maze Therapeutics
          Shionogi licenses Pompe disease therapy from Maze Therapeutics

          MazeTherapeuticsCEOJasonColomaCourtesyAfterseeingitslastdealgobustinthefaceofregulatoryscrutiny,Maze

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

          SteffenTrumpf/picturealliance/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday?